UBE2M and intrahepatic cholangiocarcinoma: Increasing evidence shows that UBE2M expression is upregulated in many malignancies, including osteosarcoma [16], urothelial carcinoma [17], and intrahepatic cholangiocarcinoma [18], suggesting that UBE2M might be associated with onset and progression of human cancers.